Delivery Order SPE2DB20D2104-SPE2DB23FQ85S
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,324.32 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 15 ml, with a performance period ending on February 1, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $1,097.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LOTEPREDNOL ETABONATE 0.2% DRP 5ML, a pharmaceutical eye drop product. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- This federal contract award, valued at $2,463.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LOTEPREDNOL DROPS 1S, a pharmaceutical product, with a period of performance through March 22, 2024. This award is not designated as a set-aside contract. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value...
- This federal contract award is for the delivery of loteprednol etabonate 0.5% eye drops, in 5 ml quantities, to the Defense Logistics Agency (DLA). The $2,143.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2023, with an ultimate completion date of March 2, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,631.68 delivery order contract is for the supply of Loteprednol Etabonate 0.5% eye drops, a pharmaceutical product. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB22FH3T6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,721.04 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% eye drops. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key supplier to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) for the delivery of Loteprednol 0.5% ophthalmic gel 5GM. The contract has a ceiling value of $1,848.57 and a completion date of September 28, 2023. This is a Firm Fixed Price Delivery Order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $1,721.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Loteprednol Etabonate 0.5% DRP 5ML, a prescription medication. The contract has an ultimate completion date of July 3, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FQ85SDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/25/22 |